… Coronary microembolization (CME) can lead to slow or even lack of reflow in the myocardium
and occurs due to percutaneous coronary intervention (PCI) for acute coronary syndrome …

… Coronary microembolization (CME) commonly occurs during thrombolytic therapy or
percutaneous coronary intervention. CME is caused by atherosclerotic unstable plaques rupturing …

… Coronary microembolization (CME) is associated with cardiomyocyte apoptosis and cardiac
… could alleviate cardiomyocyte apoptosis and improve cardiac function following CME. The …

… Coronary microembolization (CME) is an intractable complication results from acute coronary
… CME-induced myocardial apoptosis was associated with progressive cardiac contractile …

… In summary, GSK-3 β is involved in the damage to cardiac function induced by CME and
shows obvious time variation, which may be achieved by regulating the expression of …

Objective Coronary microembolization (CME) results in progressive contractile dysfunction
associated with cardiomyocyte apoptosis. Alprostadil injection improves microcirculation, …

… in the presentation of acute coronary syndromes. An associated … We propose that coronary
microembolization is a decisive … and mechanisms of coronary microembolization and discuss …

… mtDNA copy number and formation of microemboli. Adjusting dosages of PGE1 might …
GSK-3β in this study. Hence, we cannot exclude the possibility that our findings regarding GSK-3β …

ams 2 2007.qxp Page 1 The interaction of coronary microembolization and ischemic
preconditioning: A third window of cardioprotection through TNF-alpha Philipp Heusch1, Andreas …

… Background: Coronary microembolisation (CME)-induced myocardial apoptosis is a key
factor in progressive cardiac dysfunction. Aloperine (ALO) plays a protective role in the …